RVMD
Revolution Medicines Inc

1,586
Mkt Cap
$18.8B
Volume
1.47M
52W High
$124.49
52W Low
$29.17
PE Ratio
-16.03
RVMD Fundamentals
Price
$94.86
Prev Close
$95.07
Open
$96.44
50D MA
$101.72
Beta
1.08
Avg. Volume
2.39M
EPS (Annual)
-$5.95
P/B
11.46
Rev/Employee
$0.00
$13,545.26
Loading...
Loading...
News
all
press releases
General Atlantic L.P. Acquires New Position in Revolution Medicines, Inc. $RVMD
General Atlantic L.P. acquired a new stake in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange...
MarketBeat·12h ago
News Placeholder
More News
News Placeholder
Victory Capital Management Inc. Trims Stock Holdings in Revolution Medicines, Inc. $RVMD
Victory Capital Management Inc. lowered its stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 31.4% during the third quarter, according to the company in its most recent...
MarketBeat·2d ago
News Placeholder
Handelsbanken Fonder AB Grows Position in Revolution Medicines, Inc. $RVMD
Handelsbanken Fonder AB increased its holdings in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 25.1% in the third quarter, according to its most recent 13F filing with the...
MarketBeat·10d ago
News Placeholder
Revolution Medicines (NASDAQ:RVMD) Insider Mark Goldsmith Sells 30,000 Shares
Revolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) insider Mark Goldsmith sold 30,000 shares of the business's stock in a transaction on Monday, March 2nd. The shares were sold at an average...
MarketBeat·11d ago
News Placeholder
Revolution Medicines, Inc. $RVMD Shares Purchased by Legato Capital Management LLC
Legato Capital Management LLC increased its stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 130.8% during the third quarter, according to the company in its most recent...
MarketBeat·11d ago
News Placeholder
Revolution Medicines, Inc. (NASDAQ:RVMD) Receives Average Rating of "Buy" from Brokerages
Revolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) has received a consensus recommendation of "Buy" from the twenty brokerages that are presently covering the firm, MarketBeat reports. One...
MarketBeat·12d ago
News Placeholder
Revolution Medicines, Inc. $RVMD Shares Bought by Rafferty Asset Management LLC
Rafferty Asset Management LLC lifted its position in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 17.6% during the third quarter, according to the company in its most recent...
MarketBeat·12d ago
News Placeholder
What is Lifesci Capital's Forecast for RVMD Q1 Earnings?
Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) - Analysts at Lifesci Capital reduced their Q1 2026 earnings per share estimates for Revolution Medicines in a report released on Wednesday...
MarketBeat·13d ago
News Placeholder
Revolution Medicines, Inc. $RVMD Shares Bought by TD Asset Management Inc
TD Asset Management Inc grew its stake in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 5.5% in the third quarter, according to its most recent 13F filing with the Securities & Exchange...
MarketBeat·13d ago
News Placeholder
Revolution Medicines (NASDAQ:RVMD) Coverage Initiated at UBS Group
UBS Group started coverage on Revolution Medicines in a research note on Friday. They issued a "buy" rating for the company...
MarketBeat·15d ago
<
1
2
...
>

Latest RVMD News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.